Contacts
|
Content :
Events 2005
November 8, 2005 Third Quarter 2005 resultsThe 3rd quarter 2005 results are reviewed at 8 a.m (Paris time) by Mr. Hanspeter Spek, Executive Vice President Pharmaceutical Operations and Mr. Jean-Claude Leroy, Senior Vice President CFO. The presentation is followed by a Q&A session. 
August 31, 2005 2005 first-half results - Analysts/Investors Meeting in ParisStrong growth in 2005 first half adjusted EPS : up 26.1% at €2.22 
July 19, 2005 Second Quarter 2005 salesStrong net sales growth in the first half of 2005: 11.0% on a comparable basis. Further increase in market share in the second quarter 
June 13, 2005 RIO-Diabetes TrialRimonabant in patients with type 2 Diabetes 
May 31, 2005 General Meeting 2005The General Meeting of sanofi-aventis shareholders was held on May 31, 2005 in Paris. 
May 13, 2005 First Quarter 2005 sales and earnings2005 first-quarter net sales growth ahead of world pharmaceutical market growth at 11.9% on a comparable basis 
March 9, 2005 American Congress of CardiologyResults of RIO-Europe 2 years, COMMIT and CLARITY 
March 1, 2005 2004 Full-Year Results - Analysts / Investors meeting in ParisStrong growth of 18.2% in 2004 adjusted proforma EPS to 3.89 euros per share 
January 26, 2005 Fourth Quarter and Full-Year 2004 Sales release2004 pro forma combined net sales: up 10.0% on a comparable basis |
Slots : |
